{"frames":[{"target":{"name":"Craft","spans":[{"start":0,"end":1,"text":"Science"}]},"annotationSets":[{"rank":0,"score":11.691366466170551,"frameElements":[]}]},{"target":{"name":"Medical_specialties","spans":[{"start":2,"end":3,"text":"medicine"}]},"annotationSets":[{"rank":0,"score":4.571156479647906,"frameElements":[{"name":"Specialty","spans":[{"start":0,"end":3,"text":"Science translational medicine"}]}]}]}],"tokens":["Science","translational","medicine","."]}
{"frames":[{"target":{"name":"Roadways","spans":[{"start":6,"end":7,"text":"pathway"}]},"annotationSets":[{"rank":0,"score":68.26242781222399,"frameElements":[{"name":"Roadway","spans":[{"start":6,"end":7,"text":"pathway"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":9,"end":10,"text":"cancer"}]},"annotationSets":[{"rank":0,"score":37.097026595515736,"frameElements":[]}]},{"target":{"name":"Cure","spans":[{"start":10,"end":11,"text":"therapy"}]},"annotationSets":[{"rank":0,"score":40.41124638174753,"frameElements":[]}]},{"target":{"name":"Means","spans":[{"start":12,"end":13,"text":"Mechanisms"}]},"annotationSets":[{"rank":0,"score":14.027582754932027,"frameElements":[{"name":"Means","spans":[{"start":12,"end":13,"text":"Mechanisms"}]}]}]},{"target":{"name":"Response","spans":[{"start":14,"end":15,"text":"response"}]},"annotationSets":[{"rank":0,"score":40.75731363062538,"frameElements":[]}]}],"tokens":["PD-L1","-LRB-","B7-H1","-RRB-","and","PD-1","pathway","blockade","for","cancer","therapy",":","Mechanisms",",","response","biomarkers",",","and","combinations","."]}
{"frames":[{"target":{"name":"Roadways","spans":[{"start":6,"end":7,"text":"pathway"}]},"annotationSets":[{"rank":0,"score":68.18194566113964,"frameElements":[{"name":"Roadway","spans":[{"start":6,"end":7,"text":"pathway"}]}]}]},{"target":{"name":"Omen","spans":[{"start":11,"end":12,"text":"promising"}]},"annotationSets":[{"rank":0,"score":29.661051039273524,"frameElements":[]}]},{"target":{"name":"Cure","spans":[{"start":12,"end":13,"text":"therapy"}]},"annotationSets":[{"rank":0,"score":43.78004990663225,"frameElements":[]}]},{"target":{"name":"Cause_to_start","spans":[{"start":15,"end":16,"text":"elicited"}]},"annotationSets":[{"rank":0,"score":30.79705656908215,"frameElements":[{"name":"Effect","spans":[{"start":16,"end":33,"text":"durable antitumor responses and long-term remissions in a subset of patients with a broad spectrum of cancers"}]}]}]},{"target":{"name":"Response","spans":[{"start":18,"end":19,"text":"responses"}]},"annotationSets":[{"rank":0,"score":39.43838056342089,"frameElements":[]}]},{"target":{"name":"Weapon","spans":[{"start":24,"end":25,"text":"subset"}]},"annotationSets":[{"rank":0,"score":45.178501970563225,"frameElements":[{"name":"Weapon","spans":[{"start":24,"end":25,"text":"subset"}]}]}]},{"target":{"name":"Dimension","spans":[{"start":29,"end":30,"text":"broad"}]},"annotationSets":[{"rank":0,"score":21.938744341029256,"frameElements":[{"name":"Object","spans":[{"start":30,"end":31,"text":"spectrum"}]},{"name":"Dimension","spans":[{"start":29,"end":30,"text":"broad"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":32,"end":33,"text":"cancers"}]},"annotationSets":[{"rank":0,"score":42.08389663387831,"frameElements":[]}]}],"tokens":["PD-L1","and","PD-1","-LRB-","PD","-RRB-","pathway","blockade","is","a","highly","promising","therapy","and","has","elicited","durable","antitumor","responses","and","long-term","remissions","in","a","subset","of","patients","with","a","broad","spectrum","of","cancers","."]}
{"frames":[{"target":{"name":"Cause_to_make_progress","spans":[{"start":2,"end":3,"text":"improve"}]},"annotationSets":[{"rank":0,"score":61.35389132391705,"frameElements":[{"name":"Project","spans":[{"start":8,"end":14,"text":"the clinical response to anti-PD therapy"}]}]}]},{"target":{"name":"Cause_expansion","spans":[{"start":4,"end":5,"text":"widen"}]},"annotationSets":[{"rank":0,"score":64.06308433028808,"frameElements":[]}]},{"target":{"name":"Expectation","spans":[{"start":7,"end":8,"text":"predict"}]},"annotationSets":[{"rank":0,"score":30.012755632182397,"frameElements":[{"name":"Phenomenon","spans":[{"start":8,"end":26,"text":"the clinical response to anti-PD therapy is a central theme in the field of cancer immunology and immunotherapy"}]}]}]},{"target":{"name":"Response","spans":[{"start":10,"end":11,"text":"response"}]},"annotationSets":[{"rank":0,"score":41.53254344156632,"frameElements":[{"name":"Trigger","spans":[{"start":11,"end":14,"text":"to anti-PD therapy"}]}]}]},{"target":{"name":"Cure","spans":[{"start":13,"end":14,"text":"therapy"}]},"annotationSets":[{"rank":0,"score":40.0541743545111,"frameElements":[]}]},{"target":{"name":"Part_orientational","spans":[{"start":16,"end":17,"text":"central"}]},"annotationSets":[{"rank":0,"score":11.923301250211528,"frameElements":[{"name":"Whole","spans":[{"start":17,"end":18,"text":"theme"}]}]}]},{"target":{"name":"Topic","spans":[{"start":17,"end":18,"text":"theme"}]},"annotationSets":[{"rank":0,"score":20.54564306615773,"frameElements":[{"name":"Text","spans":[{"start":16,"end":17,"text":"central"}]},{"name":"Topic","spans":[{"start":18,"end":26,"text":"in the field of cancer immunology and immunotherapy"}]}]}]},{"target":{"name":"Fields","spans":[{"start":20,"end":21,"text":"field"}]},"annotationSets":[{"rank":0,"score":23.201619668726586,"frameElements":[{"name":"Activity","spans":[{"start":21,"end":26,"text":"of cancer immunology and immunotherapy"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":22,"end":23,"text":"cancer"}]},"annotationSets":[{"rank":0,"score":37.097026595515736,"frameElements":[]}]},{"target":{"name":"Weapon","spans":[{"start":23,"end":24,"text":"immunology"}]},"annotationSets":[{"rank":0,"score":49.53571344302437,"frameElements":[{"name":"Weapon","spans":[{"start":23,"end":24,"text":"immunology"}]},{"name":"Type","spans":[{"start":22,"end":23,"text":"cancer"}]}]}]}],"tokens":["How","to","improve",",","widen",",","and","predict","the","clinical","response","to","anti-PD","therapy","is","a","central","theme","in","the","field","of","cancer","immunology","and","immunotherapy","."]}
{"frames":[{"target":{"name":"Weapon","spans":[{"start":7,"end":8,"text":"biological"}]},"annotationSets":[{"rank":0,"score":62.08459244444752,"frameElements":[{"name":"Weapon","spans":[{"start":7,"end":8,"text":"biological"}]}]}]},{"target":{"name":"Education_teaching","spans":[{"start":8,"end":9,"text":"studies"}]},"annotationSets":[{"rank":0,"score":106.5664493695272,"frameElements":[]}]},{"target":{"name":"Place_weight_on","spans":[{"start":9,"end":10,"text":"focused"}]},"annotationSets":[{"rank":0,"score":58.722763054255736,"frameElements":[{"name":"Consideration","spans":[{"start":10,"end":15,"text":"on the human cancer microenvironment"}]},{"name":"Agent","spans":[{"start":0,"end":9,"text":"Oncologic , immunologic , genetic , and biological studies"}]}]}]},{"target":{"name":"People","spans":[{"start":12,"end":13,"text":"human"}]},"annotationSets":[{"rank":0,"score":35.6053573990596,"frameElements":[{"name":"Person","spans":[{"start":12,"end":13,"text":"human"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":13,"end":14,"text":"cancer"}]},"annotationSets":[{"rank":0,"score":37.097026595515736,"frameElements":[]}]},{"target":{"name":"Creating","spans":[{"start":16,"end":17,"text":"yielded"}]},"annotationSets":[{"rank":0,"score":74.10624077360563,"frameElements":[{"name":"Created_entity","spans":[{"start":17,"end":19,"text":"substantial insight"}]}]}]},{"target":{"name":"Point_of_dispute","spans":[{"start":21,"end":22,"text":"issue"}]},"annotationSets":[{"rank":0,"score":19.839926429168496,"frameElements":[{"name":"Question","spans":[{"start":21,"end":22,"text":"issue"}]}]}]}],"tokens":["Oncologic",",","immunologic",",","genetic",",","and","biological","studies","focused","on","the","human","cancer","microenvironment","have","yielded","substantial","insight","into","this","issue","."]}
{"frames":[{"target":{"name":"Locative_relation","spans":[{"start":0,"end":1,"text":"Here"}]},"annotationSets":[{"rank":0,"score":27.66602926970428,"frameElements":[{"name":"Ground","spans":[{"start":0,"end":1,"text":"Here"}]}]}]},{"target":{"name":"Place_weight_on","spans":[{"start":3,"end":4,"text":"focus"}]},"annotationSets":[{"rank":0,"score":54.91325557754222,"frameElements":[{"name":"Consideration","spans":[{"start":4,"end":7,"text":"on tumor microenvironment"}]},{"name":"Agent","spans":[{"start":2,"end":3,"text":"we"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":5,"end":6,"text":"tumor"}]},"annotationSets":[{"rank":0,"score":31.409946575682167,"frameElements":[]}]},{"target":{"name":"Assessing","spans":[{"start":8,"end":9,"text":"evaluate"}]},"annotationSets":[{"rank":0,"score":71.0876176671682,"frameElements":[{"name":"Assessor","spans":[{"start":2,"end":3,"text":"we"}]},{"name":"Phenomenon","spans":[{"start":9,"end":24,"text":"several potential therapeutic response markers including the PD-L1 and PD-1 expression pattern , genetic mutations"}]}]}]},{"target":{"name":"Quantity","spans":[{"start":9,"end":10,"text":"several"}]},"annotationSets":[{"rank":0,"score":25.123449366021703,"frameElements":[{"name":"Quantity","spans":[{"start":9,"end":10,"text":"several"}]},{"name":"Individuals","spans":[{"start":13,"end":14,"text":"markers"}]}]}]},{"target":{"name":"Capability","spans":[{"start":10,"end":11,"text":"potential"}]},"annotationSets":[{"rank":0,"score":37.20136971892169,"frameElements":[]}]},{"target":{"name":"Cure","spans":[{"start":11,"end":12,"text":"therapeutic"}]},"annotationSets":[{"rank":0,"score":46.42128084803626,"frameElements":[]}]},{"target":{"name":"Response","spans":[{"start":12,"end":13,"text":"response"}]},"annotationSets":[{"rank":0,"score":40.75731363062538,"frameElements":[]}]},{"target":{"name":"Inclusion","spans":[{"start":14,"end":15,"text":"including"}]},"annotationSets":[{"rank":0,"score":42.017993936793346,"frameElements":[{"name":"Part","spans":[{"start":15,"end":21,"text":"the PD-L1 and PD-1 expression pattern"}]},{"name":"Total","spans":[{"start":13,"end":14,"text":"markers"}]}]}]},{"target":{"name":"Encoding","spans":[{"start":19,"end":20,"text":"expression"}]},"annotationSets":[{"rank":0,"score":17.572236084385608,"frameElements":[]}]},{"target":{"name":"Pattern","spans":[{"start":20,"end":21,"text":"pattern"}]},"annotationSets":[{"rank":0,"score":5.456637379755122,"frameElements":[{"name":"Descriptor","spans":[{"start":16,"end":19,"text":"PD-L1 and PD-1"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":25,"end":26,"text":"cancer"}]},"annotationSets":[{"rank":0,"score":37.097026595515736,"frameElements":[]}]},{"target":{"name":"Building_subparts","spans":[{"start":26,"end":27,"text":"cells"}]},"annotationSets":[{"rank":0,"score":20.462009737487644,"frameElements":[{"name":"Building_part","spans":[{"start":26,"end":27,"text":"cells"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":30,"end":31,"text":"cancer"}]},"annotationSets":[{"rank":0,"score":37.097026595515736,"frameElements":[]}]},{"target":{"name":"Building_subparts","spans":[{"start":35,"end":36,"text":"cell"}]},"annotationSets":[{"rank":0,"score":15.545259178609346,"frameElements":[{"name":"Building_part","spans":[{"start":35,"end":36,"text":"cell"}]}]}]}],"tokens":["Here",",","we","focus","on","tumor","microenvironment","and","evaluate","several","potential","therapeutic","response","markers","including","the","PD-L1","and","PD-1","expression","pattern",",","genetic","mutations","within","cancer","cells","and","neoantigens",",","cancer","epigenetics","and","effector","T","cell","landscape",",","and","microbiota","."]}
{"frames":[{"target":{"name":"Increment","spans":[{"start":1,"end":2,"text":"further"}]},"annotationSets":[{"rank":0,"score":13.717567093101167,"frameElements":[]}]},{"target":{"name":"Means","spans":[{"start":4,"end":5,"text":"mechanisms"}]},"annotationSets":[{"rank":0,"score":15.735775284791782,"frameElements":[{"name":"Agent","spans":[{"start":0,"end":1,"text":"We"}]},{"name":"Means","spans":[{"start":4,"end":5,"text":"mechanisms"}]},{"name":"Purpose","spans":[{"start":5,"end":13,"text":"of action of these markers and their roles"}]}]}]},{"target":{"name":"Intentionally_act","spans":[{"start":6,"end":7,"text":"action"}]},"annotationSets":[{"rank":0,"score":62.02542815364721,"frameElements":[]}]},{"target":{"name":"Performers_and_roles","spans":[{"start":12,"end":13,"text":"roles"}]},"annotationSets":[{"rank":0,"score":50.94649719169114,"frameElements":[]}]},{"target":{"name":"Shapes","spans":[{"start":14,"end":15,"text":"shaping"}]},"annotationSets":[{"rank":0,"score":11.41575532704989,"frameElements":[]}]},{"target":{"name":"Shapes","spans":[{"start":17,"end":18,"text":"shaped"}]},"annotationSets":[{"rank":0,"score":10.643554617744048,"frameElements":[]}]},{"target":{"name":"Expectation","spans":[{"start":20,"end":21,"text":"predicting"}]},"annotationSets":[{"rank":0,"score":24.626998146027454,"frameElements":[]}]},{"target":{"name":"Cure","spans":[{"start":21,"end":22,"text":"therapeutic"}]},"annotationSets":[{"rank":0,"score":46.42128084803626,"frameElements":[]}]},{"target":{"name":"Response","spans":[{"start":22,"end":23,"text":"responses"}]},"annotationSets":[{"rank":0,"score":40.08152458031519,"frameElements":[]}]}],"tokens":["We","further","clarify","the","mechanisms","of","action","of","these","markers","and","their","roles","in","shaping",",","being","shaped",",","and/or","predicting","therapeutic","responses","."]}
{"frames":[{"target":{"name":"Discussion","spans":[{"start":2,"end":3,"text":"discuss"}]},"annotationSets":[{"rank":0,"score":76.79197384383762,"frameElements":[{"name":"Interlocutor_1","spans":[{"start":0,"end":1,"text":"We"}]},{"name":"Topic","spans":[{"start":3,"end":18,"text":"a variety of combinations with PD pathway blockade and their scientific rationales for cancer treatment"}]}]}]},{"target":{"name":"Type","spans":[{"start":4,"end":5,"text":"variety"}]},"annotationSets":[{"rank":0,"score":21.054448659347557,"frameElements":[{"name":"Subtype","spans":[{"start":4,"end":5,"text":"variety"}]},{"name":"Category","spans":[{"start":5,"end":18,"text":"of combinations with PD pathway blockade and their scientific rationales for cancer treatment"}]}]}]},{"target":{"name":"Roadways","spans":[{"start":9,"end":10,"text":"pathway"}]},"annotationSets":[{"rank":0,"score":68.09440429037132,"frameElements":[{"name":"Roadway","spans":[{"start":9,"end":10,"text":"pathway"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":16,"end":17,"text":"cancer"}]},"annotationSets":[{"rank":0,"score":37.097026595515736,"frameElements":[]}]},{"target":{"name":"Cure","spans":[{"start":17,"end":18,"text":"treatment"}]},"annotationSets":[{"rank":0,"score":43.03640539678227,"frameElements":[]}]}],"tokens":["We","also","discuss","a","variety","of","combinations","with","PD","pathway","blockade","and","their","scientific","rationales","for","cancer","treatment","."]}
